NCT02151175
Low-intensity Focused Ultrasound Pulsation (LIFUP) for Treatment of Temporal Lobe Epilepsy
Enrolling by Invitation
NAAges 18–60InterventionalBasic scienceBrainSonix Inc.
~12 participants
Updated 2024-08-06 on ClinicalTrials.gov
What's tested:LIFUP
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Absence of histological changes
Measured over 7 days
Conditions
Where it's being run
1 sites across 1 statesCalifornia1
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Subjects with clinical evidence from their diagnostic evaluations of unilateral hippocampal dysfunction and epileptogenicity.
Subjects with seizures that have been refractory to treatment with at least three currently marketed antiepileptic drugs.
Subjects with epilepsy who would clearly benefit from surgical intervention.
Subjects who have been offered a non-dominant anterior-mesial temporal lobe resection as treatment for medication refractory epilepsy.
Exclusion
Subjects with a cognitive or psychiatric disorder that limits the ability to give informed consent or are unable to cooperate with the testing.
Subjects with dementia, delirium and psychotic symptoms. - Subjects with ferromagnetic materials in the head.
Subjects with severe cardiac disease, increased intracranial pressure, or a TENS unit.
Subjects who exhibit primary generalized seizures or pseudoseizures.
Subjects who have seizures secondary to drugs, alcohol, metabolic illness or progressive degenerative disease.
Subjects who have experienced status epilepticus during the 3-week baseline period prior to the operation.
Subjects (females) who are pregnant.
What this trial measures
- Absence of histological changes7 days